QMENTA is pleased to be collaborating with Harvard’s the Athinoula A. Martinos Center for Biomedical Imaging and the University of Rochester in supporting an exciting research challenge open to image...
QMENTA News
QMENTA’s Quality Management System (QMS) is a company-wide new initiative, which has enhanced the quality of our products & services and improved our system on patient safety. We have...
BOSTON, MA, February 6th 2019 – QMENTA – the data-driven, AI-powered company, that aims to revolutionize the way medical imaging is used in clinical trials and clinical care – welcomes Pablo...
We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November 25th to November 30th, booth 7665 PCT in Barcelona...
BOSTON, MA & CAMBRIDGE, MA – QMENTA and Amylyx Pharmaceuticals today announced a collaboration to support Amylyx’s upcoming clinical trial of AMX0035 in Alzheimer’s disease. QMENTA will use its...
A poor functional outcome of stroke patients may be predicted by early signs on CT and MRI. Radiology exams carried out within 6 hours after stroke onset can contain important insights supporting the...
Impact of psychiatric disorders in the world. The World Health Organization estimates that around 450 million people suffer from psychiatric disorders. They predict that one in four people in the...
Boston: QMENTA – The innovative platform for clinical trials and research, providing an all-in-one platform that enables secure and compliant data aggregation and transfer in addition to AI-powered...
Stroke is the 5th leading cause of death in the world with numbers reaching up to 615.000 dead in Europe, 800.000 dead in the US and 15 million globally each year.(1–3) The burden of the disease...
In only a couple of years, VivaTech has become one of the most innovative events for startups. The third edition will take place in Paris from May 24th – 26th and will once again gather leaders from...